Transcription inhibition: a potential strategy for cancer therapeutics

[引用][C] Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer

R Soong, M Salto-Tellez, BC Goh - 2006
相关文章